Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification.
about
Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Anti-tumor efficacy of theliat ...... ession and gene amplification.
@en
type
label
Anti-tumor efficacy of theliat ...... ession and gene amplification.
@en
prefLabel
Anti-tumor efficacy of theliat ...... ession and gene amplification.
@en
P2093
P2860
P356
P1433
P1476
Anti-tumor efficacy of theliat ...... ession and gene amplification.
@en
P2093
Dongxia Shi
Haibin Yang
Huaqing Cai
Jianming Zheng
Linfang Wang
Longxian Jiao
P2860
P304
50832-50844
P356
10.18632/ONCOTARGET.17243
P407
P577
2017-04-19T00:00:00Z